Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 20, Issue 37, Pages 5801-5810Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612820666140212205848
Keywords
Extracellular matrix mineralization; vascular calcification; mineralization inhibitors; animal models
Categories
Funding
- Canadian Institute of Health Research
- Faculty of Dentistry, McGill University
Ask authors/readers for more resources
Mineralization of bone and tooth extracellular matrix (ECM) is a physiologic process, while soft tissue mineralization, also known as ectopic mineralization (calcification), is a pathologic condition. Vascular calcification is common in aging and also in a number of genetic and metabolic disorders. The calcific deposits in arteries complicate the prognosis and increase the morbidity in diseases such as atherosclerosis, diabetes and chronic kidney disease (CKD). To completely understand the pathophysiology of these life-threatening diseases, it is critical to elucidate the molecular mechanisms underlying vascular calcification. Unveiling these mechanisms will eventually identify new therapeutic targets and also improve the management of the associated complications. In the current review, we discussed the common determinants of ECM mineralization, the mechanism of vascular calcification associated with several human diseases and outlined the most common therapeutic approaches to prevent its progression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available